Bioscience Biotechnology Research Communications

An Open Access International Journal

P-ISSN: 0974-6455 E-ISSN: 2321-4007

Bioscience Biotechnology Research Communications

An Open Access International Journal

Anshu Makkar, and Mohit Bhardwaj

Department of Medicine Shree Guru Gobind Singh Tricentary

University, Gurugram, Haryana, India

Department of Pulmonary Medicine Shree Guru Gobind Singh Tricentary

University, Gurugram, Haryana, India

Corresponding author email: anshumakkar2010@gmail.com

Article Publishing History

Received: 19/05/2021

Accepted After Revision: 28/07/2021

ABSTRACT:

COVID-19 infectious disease triggered by SARS-CoV-2 widely spread over almost 200 countries. More than 7.5 million people are affected and approximately 1.15 lakh people died due to COVID-19 pandemic. SARS-CoV-2 is not only accountable for the disease of pneumonia but has bad effect on the body’s organs including lungs, kidneys, liver and heart. Patients who are suffering from end-stage kidney disease are at greater risk with COVID-19.Kidney complications are increased due to the infection caused by SARS-CoV-2 thatmay arisecaused by direct effect of cytopathic, renal-toxic therapies or multi-organ dysfunction. In the case of COVID-19, low oxygen delivery to the kidney tissues leads to the ischemic damage of the kidney. Since kidney is one of the important organs of the body that provide essential function to the body,this review is focused on the effect of SARS-CoV-2 novel coronavirus on kidneys.

KEYWORDS:

Acute kidney Injury (AKI), Coronavirus, COVID-19 Pandemic, SARS-CoV-2, Renal Failure

Download this article as:

Copy the following to cite this article:


Copy the following to cite this URL: